<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=1400074&amp;fmt=gif">

Biopharma Solutions

Companion diagnostic partnering

We strive to hold ourselves to the highest quality standard so we can arm our biopharma partners with superior diagnostic solutions to overcome the challenges and risks associated with drug discovery, development and commercialization through strategic companion diagnostic (CDx) partnering.

Joint CDx Partnering Solution

We provide end-to-end CDx partnering solutions for our biopharma clients from initial biomarker discovery to commercialization.

bdx-graphic-CDx-02

Why is CDx Partnering Beneficial?

  • Increase probability of success for pivotal trials
  • Accelerate FDA approval of new therapies
  • Identify patient populations who will experience the greatest benefit from new therapies
  • Realize greater efficiency in clinical development

Why Partner With Us?

  • We adapt business models that fit our partnership needs
  • We are actively engaging in IVD programs
  • We have a blood-based, multi-omic approach to biomarker discovery
  • We have significant experience gaining wide-spread U.S. reimbursement for novel clinical diagnostics
  • We have two best-in-class laboratories that maintain the highest level of compliance beyond the minimal clinical laboratory certification

"We believe this type of innovative partnership between a therapeutic and a molecular diagnostic company is important to advancing personalized medicine."

– AVEO ONCOLOGY

Get in touch

Contact us

Data library

Discover more